Suryaa Now National News Desk: The central government has initiated measures to make cancer treatment more accessible by implementing trade margin rationalization (TMR) on 137 non-scheduled anti-cancer drugs. The National Pharmaceutical Pricing Authority (NPPA) has issued directives to strictly monitor the enforcement of these margins.
The NPPA confirmed that the revised maximum retail prices (MRP) came into effect on November 9, 2026, following a gazette notification issued on October 17. The list of revised prices, based on applications submitted by pharmaceutical companies, has been made available on the NPPA website, the 'Pharma Sahi Daam' portal, and the associated mobile application.
Manufacturers, retailers, dealers, stockists, hospitals, and medical institutions are required to adhere to the revised prices and must prominently display the price lists on their premises and websites. The NPPA has warned that any violations will result in action under the Drugs (Prices Control) Order (DPCO).
State drug controllers have been requested to monitor the implementation of these prices. Consumers can report grievances regarding drug pricing through the 'Pharma Sahi Daam' application or via designated helpline numbers. Experts have noted that these government measures are intended to reduce the financial burden on cancer patients.